Objective Whether severe inflammation in the background liver cirrhosis might correlate with the development of poorly differentiated human hepatocellular carcinoma (HCC) was studied in hepatitis C virus (HCV)-associated liver cirrhosis. Methods Out of 214 HCC patients who underwent curative hepatic resection, 148 patients were HCVassociated liver cirrhosis (LC) patients. Out of these 148, 31 patients with small solitary HCC nodule (diameter ! 3 cm) were included in this study. Inflammation in the background LC was evaluated by modified histology activity index (HAI). To evaluate the inflammation, piece meal necrosis, intra lobular cellular degeneration and focal necrosis, portal cellular inflammation (each 0-4) were estimated. In each case, the average HAI was calculated. The grade of malignancy of HCC was determined by World Health Organization (WHO) classification. Results The average HAI score in the cirrhotic portion in 17 patients with poorly differentiated HCC (5.21±1.15, mean ± standard deviation (SD)) was significantly larger than that in 14 patients without poorly differentiated HCC (4.05±0.83, p<0.005). The occurrence rate of HCC containing poorly differentiated HCC component in the patients whose HAI was more than 5.0 was 80.0% (12 out of 15), and was significantly higher compared with those in patients whose HAI was less than 5.0 (5 out of 16, 31.3%, p<0.025). In univariate and multivariate analyses for contribution to poorly differentiated HCC development, HAI was the only significant contributor (p=0.011, p=0.012 respectively). Conclusion It is suggested that severe inflammation in the background cirrhosis accelerates the promotion in the HCC development from HCV-associated LC.
Introduction
With regard to the relationship between tumor promotion and inflammation, Vasiliev and Moizhess (1) first reported that the growth of a small number of tumor cells was stimulated when they were placed on the surface of polymer film, and they speculated that local inflammation around the im-planted film might promote tumor cell proliferation. They suggested that host reactions such as inflammation may cause or promote tumorigenesis or tumor growth. Subsequently, Hamada et al. (2) succeeded in converting ER-1, a weakly tumorigenic cloned cell line of a rat mammary carcinoma, into a highly tumorigenic and metastatic cell line by interaction with host cells reactive to a foreign body (plastic plates). They attributed this phenomenon to the cytokines such as Interleukin-6 (IL-6) derived from host reactive inflammatory cells crowded around the foreign body. Considering the above findings, there is a possibility that the same mechanism is involved in the development of human hepatocellular carcinoma (HCC), and that the promotion of HCC is accelerated by severe inflammation and that histologically more advanced HCC (poorly differentiated HCC) develops as a result, in the cirrhotic liver of patients with hepatitis C virus (HCV)-associated cirrhosis.
We investigated the relationship between the severity of inflammation as estimated using a modified version of the histology activity index of Knodell et al. (3) (modified Knodell's HAI) in the background LC portion and the occurrence rate of poorly differentiated HCC in the resected specimen of HCV-associated cirrhotic patients with small solitary and nodular HCC less than or equal to 3 cm in diameter.
Materials and Methods

Study population
Curative hepatic resection for HCC was performed in 214 patients in the Kanagawa Cancer Center Hospital between March 23, 1998 and October 26, 2011. Thirty-one patients who were positive for hepatitis B surface antigen were excluded. We also excluded 14 habitual alcohol drinkers who took >40 g of ethanol daily and those who drank >3 days per a week. Of the remaining 169 patients, 148 patients were anti-HCV-positive or HCV-RNA positive. Out of the 148 patients, 52 patients revealed only one (solitary) HCC nodule on the background of liver cirrhosis or pre-cirrhosis. Of the 52 patients, 31 patients had small HCC nodules of equal to or less than 3 cm in maximum diameter, and were included in this study. The reason why we selected patients with small HCC nodules of equal to or less than 3 cm in diameter was that it is well documented that HCC nodules grow larger in accordance with the tumor progression and the conversion from well or moderately differentiated HCC to the poorly differentiated HCC might occur in those with a diameter of approximately 2-3 cm.
This study was carried out according to the Declaration of Helsinki in 1995, and approved by Ethics Committee of the Kanagawa Cancer Center. All subjects gave informed consent.
Pathological evaluation
For the evaluation of inflammation in the background liver cirrhosis (LC), modified Knodell's HAI (3) was used. For the evaluation of pure inflammation, the item of fibrosis was omitted. Piece meal necrosis (0-4), intra lobular cellular degeneration and focal necrosis (0-4), and portal cellular inflammation (0-4) were estimated by two highly experienced pathologists. In each case, the HAI score was estimated in five fields (10×10 folds) and the average HAI score was calculated. All sections of resected HCC nodules were examined pathologically in all patients to determine the grade of malignancy according to World Health Organization (WHO) histological grading (4) , an authorized and extensively-used histological classification. The purpose of the study and presumed results of the study were not disclosed to the pathologists. This study was carried out according to the Declaration of Helsinki; all patients provided written informed consent, and the study protocol was approved by the Human Research Review Committee of Kanagawa Cancer Center.
Statistical analyses
Statistical differences in the characteristics between HCC patients with poorly differentiated component and those without were analyzed by use of the Mann-Whitney U test (two-tail) or Fisher's exact p value (two-tail). Univariate logistic regression analysis was performed to assess items that potentially affect poorly differentiated HCC development. Multivariate logistic regression analysis was applied to adjust for confounding factors among the items and to determine the most influential factor affecting poorly differentiated HCC development. A p-value of <0.05 was considered to indicate statistical significance. Table 1 shows the relationship between modified histology activity index (HAI) (3) and the occurrence of poorly differentiated HCC. All eight patients whose HAI was equal to or greater than 5.6 had poorly differentiated HCC component. All six patients whose HCC nodules contained well differentiated component had HAI of equal to or less than 4.7. Furthermore, the average HAI in those patients whose HCC revealed mixed type of well and moderately differentiated HCC was as low as 3.73±9.77 (means ± standard deviation (SD)), and it was significantly low compared with that in patients with mixed type of moderately and poorly differentiated HCC (5.18±1.19, p<0.02). Table 2 shows the relationship between modified Knodell's HAI and occurrence rate of poorly differentiated HCC cases in patients with HCV-related LC and HCC. The occurrence rate of HCC containing poorly differentiated HCC component in the patients whose HAI was equal to or more than 5.0 was as high as 80.0% (12 out of 15), and it was significantly higher than that of the patients whose HAI was less than 5.0% (5 out of 16, 31.3%, p<0.025). The mean maximum diameter in the former patients was 21.7±7.1 mm (mean ± SD) and that in the latter patients was 22.3±6.7 mm. There was no significant difference between the two groups. Table 3 shows the difference in HAI in the non-cancerous cirrhotic portion between HCV-related LC patients with poorly differentiated HCC component and those without poorly differentiated HCC component. The average HAI in the patients with poorly differentiated HCC component was 5.21±1.15 (mean ± SD), and it was significantly larger than that in HCC patients without poorly differentiated HCC (4.05±0.83, p<0.005). Table 4 shows the characteristics of HCC patients with and without poorly differentiated HCC component at the time of operation. No significant difference was found between the two groups. Neither the ratio of capsular formation nor vascular invasion showed a significant difference between the two groups. The mean maximum diameter of the HCC nodules in the former patient group was 22.0±6.8 mm (mean ± SD), and it was coincidentally nearly the same as those in the latter group (22.0± 6.9 mm Table 4 ). Table 5 shows the risk contribution to poorly differentiated HCC development in a univariate logistic model. HAI was the only significant contributor (p=0.011). Table 6 shows the risk contribution to poorly differentiated HCC development in a multivariate logistic model. Again, HAI was the only significant contributor (p=0.012). guided fine-needle biopsy specimens taken from 12 small early-stage HCC with those taken at autopsy. They mentioned that all tumors that had been well differentiated when evaluated by needle biopsy were found to have become moderately differentiated at autopsy. This comparative study confirmed the dedifferentiation of HCC with tumor growth (10) . Concerning the progression, Kumada et al. (11) demonstrated recently that hypointense hepatocellular nodules with maximum diameters ! 15 mm in the hepatobiliary phase of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging (Gr-EOB-MRI) become hypervascular (vascularized nodules) at rates of 43.3% and 77.3% during 6 months and 12 months, respectively. Their study suggested that the conversion of dysplastic nodules or well differentiated HCC nodules to moderately differentiated or poorly differentiated HCC nodules would occur in a relatively short period of approximately 6-12 months. It thus seems reasonable to presume an effect of severe inflammation on the promotion in HCC development from the HAI of the non-cancerous LC portion of the operative specimen at hepatectomy. The present study was aimed at disclosing the relationship between severe inflammation in the background cirrhotic portion and the promotion of HCC. We postulated that severe inflammation might expedite tumor promotion and poorly differentiated HCC component might develop in a relatively high percentage of HCV-LC patients with severe inflammation. To investigate this problem, pathologic examination of the resected small HCC seems to be essential.
Results
Okuda (12) investigated solitary nodular lesions in the liver and found that the average size of adenomatous hyperplasia (AH, dysplastic nodule) was around 1 cm in diameter, atypical AH 1.2 cm, early HCC 1.3 cm, well diffentiated HCC 1.6 cm and classic HCC 2.2 cm. Considering this report, it was reasonable to examine small resected HCC in which the maximum diameter was equal to or less than 3 cm in our study. We also demonstrated in this study that the average HAI in the non-cancerous cirrhotic portion of HCC patients with poorly differentiated HCC was significantly larger than that in patients without poorly differentiated HCC. In addition, the average maximum diameter of the HCC nodules in the former was just the same as that in the latter (2.2 cm). Furthermore, the occurrence rate of HCC containing the poorly differentiated HCC component in the HCC patients whose HAI of the background LC was equal to or more than 5.0, was significantly higher than that in those whose HAI was less than 5.0. In support of these phenomenon, we also demonstrated that all 8 patients whose HAI was equal to or more than 5.6 contained the poorly differentiated HCC component, as contrasted with all 6 patients whose nodule contained well differentiated HCC component were having HAI equal to or less than 4.7.
With regard to the relationship between the severe inflammation and the HCC development in HCV-related chronic liver diseases, many studies have demonstrated the close association between severe inflammation as estimated by higher serum alanine aminotransferase level and initiation of HCC development (13) (14) (15) . However, no study has ever demonstrated the relationship between severe inflammation and the promotion of HCC tumor in HCV-related chronic liver diseases. The present study clearly demonstrated that relationship. While, it is accepted that the histological severity of inflammation is correlated with the elevation of transaminases, there are some reports which demonstrate a discrepancy between histological inflammation and transaminases. The reason why no difference was recognized between the two groups was not explained accurately but it might be due to the small size of the patient groups.
The results in this study are in accordance with our previous demonstration that a significant correlation exists between DNA synthesis by HCC cells and that by hepatocytes from the background cirrhosis, using in vitro bromodeoxyuridine (Brd U)-anti Brd U method. In other words, if the Brd U labeling index in the background cirrhotic portion increases as a result of severe inflammation, the more malignant HCC cells might develop with increased deoxyribonucleic acid (DNA) synthesis (16) .
Although a critical role for chronic persistent inflammation in carcinogenesis is now generally accepted, the role of inflammatory microenvironment surrounding solid tumors in tumor progression is much more complicated. The tumor microenvironment contains a variety of innate immune cells such as macrophages, neutrophils, mast cells, dendritic cells, or natural killer cells, and adaptive immune cells of T and B lympsocytes (17) . Additionally, numerous factors are involved; it is the type of immune mediators or modulators produced as well as abundance and activation state of different types of immune cells in the tumor microenvironment that determines the direction as to whether inflammation works for tumor promotion or antitumor immunity (18, 19) . Tumor necrotizing factor (TNF)-alpha and IL-6 are found as tumor-promoting cytokines in hepatocellular carcinomas in mice models through activating transcription factors nuclear factor kappaB (NF-kappaB) and signal transducers and activators of transcription 3 (STAT3) (20, 21) . In addition, in the tumor cell killing immune responses, reactive oxygen species and reactive nitrogen intermediates produced by activated neutrophils and macrophages could induce DNA damage and genomic instability of tumor cells (19) , which may serve for a genetic background of tumor malignant progression. Precise analyses of the types of infiltrating immune cells and cytokines produced by such cells are our major points of focus following the present study.
It is well known that histological grading (EdmondsonSteiner's, E-S grading (22)) of HCC tumors affects the postoperative prognosis of the patients (23) (24) (25) . Zhou et al. (23) demonstrated that histological grading (E-S grading) increases the predictive efficiency of tumor-nodes-metastasis classification (TNM) staging for long-term survival of patients with hepatocellular carcinoma after curative resection. They stated that in a Cox regression test enrolling TNM-5 and TNM-6, histological grading was the sole independent predictor of overall and disease-free survival for both. Additionally, they stated that higher histological grades were shown to be associated with shorter overall and disease-free survival of HCC patients after curative hepatic resection. Additionally, Asahara et al. (24) analyzed factors affecting the postoperative prognosis in the solitary-nodular type of hepatocellular carcinoma, and found that prognostic factors for non-recurrence included histological (E-S) grading.
Our findings in this study suggest that we might be able to prevent the tumor promotion or progression of HCC (from well differentiated to moderately or poorly differentiated) by anti-inflammatory therapy including interferon therapy in HCV-associated LC with HCC. Such an effort would be important because it is accepted that the prognosis of cirrhotic patients with poorly differentiated HCC is worse than that of those with well differentiated or moderately differentiated HCC as mentioned above. The drugs which are proven nowadays to alleviate inflammation in HCVassociated liver disease by significantly decreasing the serum alanine aminotransferase level are interferon (25) (26) (27) (28) (29) , ursodeoxycholic acid (30, 31) and herbal medicine (Strongerneominophagen C (32, 33), Sho-saiko-to (34, 35) , and Juzen-taiho-to (36)). However, prospective trials using antiinflammatory agents including interferon therapy are necessary to confirm a positive impact of anti-inflammatory therapy on the prevention of HCC promotion.
In conclusion, it is strongly suggested that severe inflammation in the background non-cancerous cirrhotic portion might accelerate the promotion to poorly differentiated HCC in patients with HCV-associated LC and HCC. Moreover, the possibility of inhibiting such HCC tumor promotion with anti-inflammatory agents including interferon was suggested.
